Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report offers an overview of the market trends, drivers, and barriers with respect to the China Immunotherapy market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Immunotherapy market. Detailed analysis of key players, along with key growth strategies adopted by Immunotherapy industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Merck
Johnson & Johnson
Amgen, Inc
Celgene
Roche
Novartis
Bristol-Myers Squibb
Abbvie
Biogen
Pfizer
By Type:
Monoclonal Antibodies
Therapeutic Vaccines
Checkpoint Inhibitors
Non-Specific Immunotherapy
By End-User:
Sublingual Immunotherapy
Subcutaneous Immunotherapy
By Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Immunotherapy Market
-
1.3 Market Segment by Type
-
1.3.1 China Immunotherapy Market Size and Growth Rate of Monoclonal Antibodies from 2016 to 2027
-
1.3.2 China Immunotherapy Market Size and Growth Rate of Therapeutic Vaccines from 2016 to 2027
-
1.3.3 China Immunotherapy Market Size and Growth Rate of Checkpoint Inhibitors from 2016 to 2027
-
1.3.4 China Immunotherapy Market Size and Growth Rate of Non-Specific Immunotherapy from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 China Immunotherapy Market Size and Growth Rate of Sublingual Immunotherapy from 2016 to 2027
-
1.4.2 China Immunotherapy Market Size and Growth Rate of Subcutaneous Immunotherapy from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 North China Immunotherapy Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 Central China Immunotherapy Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 South China Immunotherapy Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 East China Immunotherapy Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.5 Northeast China Immunotherapy Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.6 Southwest China Immunotherapy Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.7 Northwest China Immunotherapy Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Immunotherapy Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Immunotherapy by Major Types
-
3.4.1 Market Size and Growth Rate of Monoclonal Antibodies
-
3.4.2 Market Size and Growth Rate of Therapeutic Vaccines
-
3.4.3 Market Size and Growth Rate of Checkpoint Inhibitors
-
3.4.4 Market Size and Growth Rate of Non-Specific Immunotherapy
4 Segmentation of Immunotherapy Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Immunotherapy by Major End-Users
-
4.4.1 Market Size and Growth Rate of Immunotherapy in Sublingual Immunotherapy
-
4.4.2 Market Size and Growth Rate of Immunotherapy in Subcutaneous Immunotherapy
5 Market Analysis by Regions
-
5.1 China Immunotherapy Production Analysis by Regions
-
5.2 China Immunotherapy Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on China Economy
6 North China Immunotherapy Landscape Analysis
-
6.1 North China Immunotherapy Landscape Analysis by Major Types
-
6.2 North China Immunotherapy Landscape Analysis by Major End-Users
7 Central China Immunotherapy Landscape Analysis
-
7.1 Central China Immunotherapy Landscape Analysis by Major Types
-
7.2 Central China Immunotherapy Landscape Analysis by Major End-Users
8 South China Immunotherapy Landscape Analysis
-
8.1 South China Immunotherapy Landscape Analysis by Major Types
-
8.2 South China Immunotherapy Landscape Analysis by Major End-Users
9 East China Immunotherapy Landscape Analysis
-
9.1 East China Immunotherapy Landscape Analysis by Major Types
-
9.2 East China Immunotherapy Landscape Analysis by Major End-Users
10 Northeast China Immunotherapy Landscape Analysis
-
10.1 Northeast China Immunotherapy Landscape Analysis by Major Types
-
10.2 Northeast China Immunotherapy Landscape Analysis by Major End-Users
11 Southwest China Immunotherapy Landscape Analysis
-
11.1 Southwest China Immunotherapy Landscape Analysis by Major Types
-
11.2 Southwest China Immunotherapy Landscape Analysis by Major End-Users
12 Northwest China Immunotherapy Landscape Analysis
-
12.1 Northwest China Immunotherapy Landscape Analysis by Major Types
-
12.2 Northwest China Immunotherapy Landscape Analysis by Major End-Users
13 Major Players Profiles
-
13.1 Merck
-
13.1.1 Merck Company Profile and Recent Development
-
13.1.2 Market Performance
-
13.1.3 Product and Service Introduction
-
13.2 Johnson & Johnson
-
13.2.1 Johnson & Johnson Company Profile and Recent Development
-
13.2.2 Market Performance
-
13.2.3 Product and Service Introduction
-
13.3 Amgen, Inc
-
13.3.1 Amgen, Inc Company Profile and Recent Development
-
13.3.2 Market Performance
-
13.3.3 Product and Service Introduction
-
13.4 Celgene
-
13.4.1 Celgene Company Profile and Recent Development
-
13.4.2 Market Performance
-
13.4.3 Product and Service Introduction
-
13.5 Roche
-
13.5.1 Roche Company Profile and Recent Development
-
13.5.2 Market Performance
-
13.5.3 Product and Service Introduction
-
13.6 Novartis
-
13.6.1 Novartis Company Profile and Recent Development
-
13.6.2 Market Performance
-
13.6.3 Product and Service Introduction
-
13.7 Bristol-Myers Squibb
-
13.7.1 Bristol-Myers Squibb Company Profile and Recent Development
-
13.7.2 Market Performance
-
13.7.3 Product and Service Introduction
-
13.8 Abbvie
-
13.8.1 Abbvie Company Profile and Recent Development
-
13.8.2 Market Performance
-
13.8.3 Product and Service Introduction
-
13.9 Biogen
-
13.9.1 Biogen Company Profile and Recent Development
-
13.9.2 Market Performance
-
13.9.3 Product and Service Introduction
-
13.10 Pfizer
-
13.10.1 Pfizer Company Profile and Recent Development
-
13.10.2 Market Performance
-
13.10.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure China Immunotherapy Market Size and Growth Rate of Monoclonal Antibodies from 2016 to 2027
-
Figure China Immunotherapy Market Size and Growth Rate of Therapeutic Vaccines from 2016 to 2027
-
Figure China Immunotherapy Market Size and Growth Rate of Checkpoint Inhibitors from 2016 to 2027
-
Figure China Immunotherapy Market Size and Growth Rate of Non-Specific Immunotherapy from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2021
-
Figure Market Share by Type in 2027
-
Figure China Immunotherapy Market Size and Growth Rate of Sublingual Immunotherapy from 2016 to 2027
-
Figure China Immunotherapy Market Size and Growth Rate of Subcutaneous Immunotherapy from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2021
-
Figure Market Share by End-User in 2027
-
Figure North China Immunotherapy Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Central China Immunotherapy Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South China Immunotherapy Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure East China Immunotherapy Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast China Immunotherapy Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Southwest China Immunotherapy Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northwest China Immunotherapy Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Immunotherapy Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2020
-
Figure Market Share of TOP 5 Players in 2021
-
Figure Market Share of TOP 6 Players from 2016 to 2021
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Map of China
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Immunotherapy
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Immunotherapy by Different Types from 2016 to 2027
-
Table Consumption Share of Immunotherapy by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Monoclonal Antibodies
-
Figure Market Size and Growth Rate of Therapeutic Vaccines
-
Figure Market Size and Growth Rate of Checkpoint Inhibitors
-
Figure Market Size and Growth Rate of Non-Specific Immunotherapy
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Immunotherapy by Different End-Users from 2016 to 2027
-
Table Consumption Share of Immunotherapy by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Sublingual Immunotherapy
-
Figure Market Size and Growth Rate of Subcutaneous Immunotherapy
-
Table China Immunotherapy Production by Regions
-
Table China Immunotherapy Production Share by Regions
-
Figure China Immunotherapy Production Share by Regions in 2016
-
Figure China Immunotherapy Production Share by Regions in 2021
-
Figure China Immunotherapy Production Share by Regions in 2027
-
Table China Immunotherapy Consumption by Regions
-
Table China Immunotherapy Consumption Share by Regions
-
Figure China Immunotherapy Consumption Share by Regions in 2016
-
Figure China Immunotherapy Consumption Share by Regions in 2021
-
Figure China Immunotherapy Consumption Share by Regions in 2027
-
Table North China Immunotherapy Consumption by Types from 2016 to 2027
-
Table North China Immunotherapy Consumption Share by Types from 2016 to 2027
-
Figure North China Immunotherapy Consumption Share by Types in 2016
-
Figure North China Immunotherapy Consumption Share by Types in 2021
-
Figure North China Immunotherapy Consumption Share by Types in 2027
-
Table North China Immunotherapy Consumption by End-Users from 2016 to 2027
-
Table North China Immunotherapy Consumption Share by End-Users from 2016 to 2027
-
Figure North China Immunotherapy Consumption Share by End-Users in 2016
-
Figure North China Immunotherapy Consumption Share by End-Users in 2021
-
Figure North China Immunotherapy Consumption Share by End-Users in 2027
-
Table Central China Immunotherapy Consumption by Types from 2016 to 2027
-
Table Central China Immunotherapy Consumption Share by Types from 2016 to 2027
-
Figure Central China Immunotherapy Consumption Share by Types in 2016
-
Figure Central China Immunotherapy Consumption Share by Types in 2021
-
Figure Central China Immunotherapy Consumption Share by Types in 2027
-
Table Central China Immunotherapy Consumption by End-Users from 2016 to 2027
-
Table Central China Immunotherapy Consumption Share by End-Users from 2016 to 2027
-
Figure Central China Immunotherapy Consumption Share by End-Users in 2016
-
Figure Central China Immunotherapy Consumption Share by End-Users in 2021
-
Figure Central China Immunotherapy Consumption Share by End-Users in 2027
-
Table South China Immunotherapy Consumption by Types from 2016 to 2027
-
Table South China Immunotherapy Consumption Share by Types from 2016 to 2027
-
Figure South China Immunotherapy Consumption Share by Types in 2016
-
Figure South China Immunotherapy Consumption Share by Types in 2021
-
Figure South China Immunotherapy Consumption Share by Types in 2027
-
Table South China Immunotherapy Consumption by End-Users from 2016 to 2027
-
Table South China Immunotherapy Consumption Share by End-Users from 2016 to 2027
-
Figure South China Immunotherapy Consumption Share by End-Users in 2016
-
Figure South China Immunotherapy Consumption Share by End-Users in 2021
-
Figure South China Immunotherapy Consumption Share by End-Users in 2027
-
Table East China Immunotherapy Consumption by Types from 2016 to 2027
-
Table East China Immunotherapy Consumption Share by Types from 2016 to 2027
-
Figure East China Immunotherapy Consumption Share by Types in 2016
-
Figure East China Immunotherapy Consumption Share by Types in 2021
-
Figure East China Immunotherapy Consumption Share by Types in 2027
-
Table East China Immunotherapy Consumption by End-Users from 2016 to 2027
-
Table East China Immunotherapy Consumption Share by End-Users from 2016 to 2027
-
Figure East China Immunotherapy Consumption Share by End-Users in 2016
-
Figure East China Immunotherapy Consumption Share by End-Users in 2021
-
Figure East China Immunotherapy Consumption Share by End-Users in 2027
-
Table Northeast China Immunotherapy Consumption by Types from 2016 to 2027
-
Table Northeast China Immunotherapy Consumption Share by Types from 2016 to 2027
-
Figure Northeast China Immunotherapy Consumption Share by Types in 2016
-
Figure Northeast China Immunotherapy Consumption Share by Types in 2021
-
Figure Northeast China Immunotherapy Consumption Share by Types in 2027
-
Table Northeast China Immunotherapy Consumption by End-Users from 2016 to 2027
-
Table Northeast China Immunotherapy Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast China Immunotherapy Consumption Share by End-Users in 2016
-
Figure Northeast China Immunotherapy Consumption Share by End-Users in 2021
-
Figure Northeast China Immunotherapy Consumption Share by End-Users in 2027
-
Table Southwest China Immunotherapy Consumption by Types from 2016 to 2027
-
Table Southwest China Immunotherapy Consumption Share by Types from 2016 to 2027
-
Figure Southwest China Immunotherapy Consumption Share by Types in 2016
-
Figure Southwest China Immunotherapy Consumption Share by Types in 2021
-
Figure Southwest China Immunotherapy Consumption Share by Types in 2027
-
Table Southwest China Immunotherapy Consumption by End-Users from 2016 to 2027
-
Table Southwest China Immunotherapy Consumption Share by End-Users from 2016 to 2027
-
Figure Southwest China Immunotherapy Consumption Share by End-Users in 2016
-
Figure Southwest China Immunotherapy Consumption Share by End-Users in 2021
-
Figure Southwest China Immunotherapy Consumption Share by End-Users in 2027
-
Table Northwest China Immunotherapy Consumption by Types from 2016 to 2027
-
Table Northwest China Immunotherapy Consumption Share by Types from 2016 to 2027
-
Figure Northwest China Immunotherapy Consumption Share by Types in 2016
-
Figure Northwest China Immunotherapy Consumption Share by Types in 2021
-
Figure Northwest China Immunotherapy Consumption Share by Types in 2027
-
Table Northwest China Immunotherapy Consumption by End-Users from 2016 to 2027
-
Table Northwest China Immunotherapy Consumption Share by End-Users from 2016 to 2027
-
Figure Northwest China Immunotherapy Consumption Share by End-Users in 2016
-
Figure Northwest China Immunotherapy Consumption Share by End-Users in 2021
-
Figure Northwest China Immunotherapy Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Merck
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck
-
Figure Sales and Growth Rate Analysis of Merck
-
Figure Revenue and Market Share Analysis of Merck
-
Table Product and Service Introduction of Merck
-
Table Company Profile and Development Status of Johnson & Johnson
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Johnson & Johnson
-
Figure Sales and Growth Rate Analysis of Johnson & Johnson
-
Figure Revenue and Market Share Analysis of Johnson & Johnson
-
Table Product and Service Introduction of Johnson & Johnson
-
Table Company Profile and Development Status of Amgen, Inc
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Amgen, Inc
-
Figure Sales and Growth Rate Analysis of Amgen, Inc
-
Figure Revenue and Market Share Analysis of Amgen, Inc
-
Table Product and Service Introduction of Amgen, Inc
-
Table Company Profile and Development Status of Celgene
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Celgene
-
Figure Sales and Growth Rate Analysis of Celgene
-
Figure Revenue and Market Share Analysis of Celgene
-
Table Product and Service Introduction of Celgene
-
Table Company Profile and Development Status of Roche
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Roche
-
Figure Sales and Growth Rate Analysis of Roche
-
Figure Revenue and Market Share Analysis of Roche
-
Table Product and Service Introduction of Roche
-
Table Company Profile and Development Status of Novartis
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis
-
Figure Sales and Growth Rate Analysis of Novartis
-
Figure Revenue and Market Share Analysis of Novartis
-
Table Product and Service Introduction of Novartis
-
Table Company Profile and Development Status of Bristol-Myers Squibb
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bristol-Myers Squibb
-
Figure Sales and Growth Rate Analysis of Bristol-Myers Squibb
-
Figure Revenue and Market Share Analysis of Bristol-Myers Squibb
-
Table Product and Service Introduction of Bristol-Myers Squibb
-
Table Company Profile and Development Status of Abbvie
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Abbvie
-
Figure Sales and Growth Rate Analysis of Abbvie
-
Figure Revenue and Market Share Analysis of Abbvie
-
Table Product and Service Introduction of Abbvie
-
Table Company Profile and Development Status of Biogen
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Biogen
-
Figure Sales and Growth Rate Analysis of Biogen
-
Figure Revenue and Market Share Analysis of Biogen
-
Table Product and Service Introduction of Biogen
-
Table Company Profile and Development Status of Pfizer
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer
-
Figure Sales and Growth Rate Analysis of Pfizer
-
Figure Revenue and Market Share Analysis of Pfizer
-
Table Product and Service Introduction of Pfizer
-
